Enrique Cervera

420 total citations
22 papers, 226 citations indexed

About

Enrique Cervera is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Enrique Cervera has authored 22 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Enrique Cervera's work include Retinal Diseases and Treatments (17 papers), Retinal and Optic Conditions (10 papers) and Retinal Imaging and Analysis (8 papers). Enrique Cervera is often cited by papers focused on Retinal Diseases and Treatments (17 papers), Retinal and Optic Conditions (10 papers) and Retinal Imaging and Analysis (8 papers). Enrique Cervera collaborates with scholars based in Spain, Portugal and Mexico. Enrique Cervera's co-authors include M. Díaz-Llopis, María Miranda, Emma Arnal, Siv Johnsen‐Soriano, Francisco Bosch‐Morell, Javier Araiz, Francisco J. Romero, Salvador García Delpech, Patricia Udaondo and Luís Arias and has published in prestigious journals such as SHILAP Revista de lepidopterología, Retina and Eye.

In The Last Decade

Enrique Cervera

20 papers receiving 218 citations

Peers

Enrique Cervera
Woong-Sun Yoo South Korea
Frances M. Pool United Kingdom
J Strobel Germany
Tammy Sanders United States
Lale Koldaş Türkiye
Lisa A Herrygers United States
Woong-Sun Yoo South Korea
Enrique Cervera
Citations per year, relative to Enrique Cervera Enrique Cervera (= 1×) peers Woong-Sun Yoo

Countries citing papers authored by Enrique Cervera

Since Specialization
Citations

This map shows the geographic impact of Enrique Cervera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Cervera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Cervera more than expected).

Fields of papers citing papers by Enrique Cervera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Cervera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Cervera. The network helps show where Enrique Cervera may publish in the future.

Co-authorship network of co-authors of Enrique Cervera

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Cervera. A scholar is included among the top collaborators of Enrique Cervera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Cervera. Enrique Cervera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casado, Miguel Á., José Luís Trillo, José M. Ruiz‐Moreno, et al.. (2020). A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study. PharmacoEconomics - Open. 4(4). 615–624. 3 indexed citations
2.
López, Francisco Cabrera, Marta S. Figueroa, Enrique Cervera, et al.. (2020). <p>Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN<sup>®</sup>) and Follow-Up Considerations/Recommendations</p>. Clinical ophthalmology. Volume 14. 2091–2107. 12 indexed citations
3.
García‐Layana, Alfredo, Marta S. Figueroa, Luís Arias, et al.. (2018). Clinical Decision-Making when Treating Diabetic Macular Edema Patients with Dexamethasone Intravitreal Implants. Ophthalmologica. 240(2). 61–72. 13 indexed citations
4.
Cervera, Enrique, et al.. (2018). Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema.. SHILAP Revista de lepidopterología. 42(6). 244–250. 6 indexed citations
6.
Cervera, Enrique. (2015). Las especialidades de la transmisión de unidades productivas en la fase común o en la fase de liquidación. 81–89.
7.
García‐Layana, Alfredo, Marta S. Figueroa, Luís Arias, et al.. (2015). Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration. Journal of Ophthalmology. 2015. 1–8. 17 indexed citations
8.
Montero, Javier A., et al.. (2010). SEROUS RETINAL DETACHMENT AS A PRESENTING FEATURE OF CHRONIC MYELOGENOUS LEUKEMIA. Retinal Cases & Brief Reports. 4(4). 394–396. 3 indexed citations
9.
Johnsen‐Soriano, Siv, María Sancho‐Tello, Emma Arnal, et al.. (2010). IL-2 and IFN-gamma in the retina of diabetic rats. Graefe s Archive for Clinical and Experimental Ophthalmology. 248(7). 985–990. 31 indexed citations
10.
Gómez‐Ulla, Francisco, Maximino Abraldes, Alfredo García‐Layana, et al.. (2010). SERV clinical practice guidelines: Management of retinal vein occlusion. Archivos de la Sociedad Española de Oftalmología (English Edition). 85(9). 294–309. 1 indexed citations
11.
Arnal, Emma, María Miranda, Siv Johnsen‐Soriano, et al.. (2009). Beneficial Effect of Docosahexanoic Acid and Lutein on Retinal Structural, Metabolic, and Functional Abnormalities in Diabetic Rats. Current Eye Research. 34(11). 928–938. 70 indexed citations
12.
Díaz-Llopis, M., Patricia Udaondo, Enrique Cervera, et al.. (2009). Vitrectomía enzimática por inyección intravítrea de plasmina autóloga como tratamiento inicial de las membranas epirretinianas maculares y el síndrome de tracción vitreomacular. Archivos de la Sociedad Española de Oftalmología. 84(2). 91–100. 8 indexed citations
13.
Amselem, Luis, et al.. (2008). Inyección intravítrea de Bevacizumab (Avastin®) para profileración angiomatosa retiniana. Archivos de la Sociedad Española de Oftalmología. 83(1). 53–6. 3 indexed citations
14.
Díaz-Llopis, M., et al.. (2008). Vitrectomía enzimática por inyección intravítrea de plasmina autóloga como tratamiento inicial del edema macular diabético difuso. Archivos de la Sociedad Española de Oftalmología. 83(2). 77–84. 6 indexed citations
15.
Cervera, Enrique, M. Díaz-Llopis, Patricia Udaondo, & Salvador García Delpech. (2008). Intravitreal pegaptanib sodium for refractory pseudophakic macular oedema. Eye. 22(9). 1180–1182. 11 indexed citations
16.
Díaz-Llopis, Manuel, et al.. (2008). ENZYMATIC VITRECTOMY BY INTRAVITREAL AUTOLOGOUS PLASMIN INJECTION, AS INITIAL TREATMENT FOR DIFFUSE DIABETIC MACULAR EDEMA VITRECTOMÍA ENZIMÁTICA POR INYECCIÓN INTRAVÍTREA DE PLASMINA AUTÓLOGA COMO TRATAMIENTO INICIAL DEL EDEMA MACULAR DIABÉTICO DIFUSO. 2 indexed citations
17.
Díaz-Llopis, M., et al.. (2007). Inyección intravítrea de bevacizumab para edema macular quístico pseudofáquico resistente a esteroides. Archivos de la Sociedad Española de Oftalmología. 82(7). 447–50. 5 indexed citations
18.
Salom, David, et al.. (2007). Neurorretinopatía macular aguda. Archivos de la Sociedad Española de Oftalmología. 82(5). 307–9. 3 indexed citations
19.
Cervera, Enrique, et al.. (2006). ABNORMAL RESPONSE OF THE RETINAL PIGMENT EPITHELIUM TO PHOTODYNAMIC THERAPY IN A CHILD. Retina. 26(7). 834–836. 3 indexed citations
20.
González-Ulloa, M, et al.. (1951). [Treatment of extensive burns].. PubMed. 31(107). 159–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026